Business
MindMed has officially been added to the NASDAQ Global Market. On April 22nd, MindMed filed an 8-A12B with the SEC...
How mushrooms are taking over the healthcare industry, and how investors can profit off of this. First we will talk...
Powered by Restream https://restream.io/ What's up Psychedelic Investors?!? We have some big news for you. Atai Life Sciences will be...
Atai Life Sciences is now the second psychedelic company to list on Nasdaq, with plans to raise $100 million for...
Digital Therapeutics and Psychedelic Medicines || MindMed's SECRET WEAPON?!? MindMed (MMED / MMEDF / MMQ) and Atai's secret weapon lies...
This week in psychedelic business news:psilocybin’s genome sequencing explored, psychedelics meet artificial intelligence, and more....
Results Are OUT! Finally we see that psilocybin is MORE EFFECTIVE in treating depression than the commonly used SSRIS. This...
GH Research closed a $125 million Series B financing round to fund the advancement of its 5-MeO-DMT treatment....
Toronto's Silo Wellness is now trading on the German Stock Exchange as demand for psychedelic treatments expands....
Former NHL player Daniel Carcillo's psychedelic startup Wesana Health is preparing to take the company public....